T Cell News and Research

Latest T Cell News and Research

New plan of action aims to reduce prescription drug costs by more than 50 percent

The United States Department of Health and Human Services has announced a new plan of action and regulatory mechanisms to deliver greater benefits. These benefits aim to reduce prescription costs by more than 50 percent for the average senior without coverage.

26 Jul 2004

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Y's Therapeutics, a privately held biopharmaceutical company, said today it has submitted applications to the Ethics Committee and Ministry of Health (BfArM) in Germany to begin Phase II clinical trials for its two most advanced projects, YSIL6 for rheumatoid arthritis and YSTH2 for asthma.

26 Jul 2004

Innovative treatment for cancer patients who have previously undergone chemotherapy, surgery or radiotherapy

At the inauguration of Hadassah's new day care center of the Sidney Weisner Department of Bone Marrow Transplantation and Cancer Immunotherapy today, Prof. Shimon Slavin, head of the department, described an innovative treatment for cancer patients who have previously undergone chemotherapy, surgery and/ or radiotherapy.

26 Jul 2004

Finding helps explain how nerves connect to their targets and stop growing once there

Johns Hopkins researchers report that once a growing nerve "tastes" a certain protein, it loses its "appetite" for other proteins and follows the tasty crumbs to reach its final destination.

26 Jul 2004

Gene responsible for infertility

A paper describing discoveries about the role of a gene that is important in all animals, plants, and fungi is published in the 20 July 2004 issue of the journal Proceedings of the National Academy of Sciences.

23 Jul 2004

Gene associated with susceptibility to developing type 1 diabetes

A new gene mutation identified by researchers at Baylor College of Medicine in Houston is part of the constellation of genes associated with susceptibility to developing type 1 diabetes. It could also play a role in the devastating complications of diabetes such as kidney failure.

23 Jul 2004

New precautionary measures against the possible risk of transmission of variant Creutzfeldt Jakob Disease

The UK Department of Health (DOH) has said today that recipients of blood transfusions are to be excluded from donating blood in the future as a further precautionary measure against the possible risk of transmission of variant Creutzfeldt Jakob Disease (vCJD), Health Secretary John Reid announced today.

23 Jul 2004

Epilepsy, new therapeutic possibilities

To date epilepsy research has mainly concentrated on the transmission of the nerve cell signals to what are known as the synapses.

23 Jul 2004

New cream treatment for common form of skin cancer

The US Food and Drug Administration has approved a new treatment for some people with a very common form of skin cancer. Imiquimod cream, sold as Aldara, can now be used to treat superficial basal cell carcinoma.

23 Jul 2004

HFEA allows families to have a child who could be a tissue match for a seriously ill brother or sister

The Human Fertilisation & Embryology Authority has decided to extend the rules allowing embryos to be tested in order for families to have a child who could be a tissue match for a seriously ill brother or sister.

22 Jul 2004

Researchers discover how world’s most serous tropical diseases - Leishmaniasis is spread

Researchers at the University of Dundee with colleagues at the Liverpool School of Tropical Medicine have discovered how the sand-fly spreads one of the world’s most serous tropical diseases - Leishmaniasis.

22 Jul 2004

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Erbitux (cetuximab), offers another option for patients who have colorectal cancer that resists standard chemotherapy treatment, according to an article written by two Mayo Clinic cancer researchers published in the current edition of the New England Journal of Medicine.

21 Jul 2004

Researchers discover a mechanism that blocks replication of a retrovirus

A team of scientists led by University of Georgia researchers has discovered a naturally occurring mechanism that blocks a critical step late in retrovirus replication.

21 Jul 2004

Australian collaboration to produce cancer immunotherapy vaccines

A Brisbane based biomedical company, Tissue Therapies Limited (TIS) and the Queensland Institute of Medical Research (QIMR) have agreed on the terms of a new collaboration aimed at developing Tissue Therapies' VitroGro® cell growth technology as a platform to produce cancer immunotherapy vaccines.

21 Jul 2004

European funding to study how yeasts such as Candida cause infections among hospital patients

Dr Fritz Mühlschlegel, Reader in Medical Microbiology in the Biosciences Department at Kent and Consultant Medical Microbiologist in the East Kent NHS Trust, and Dr Daniel Poullain from Lille’s Medical School have been awarded 315,106 euros under the EU’s Interreg Programme to study the mechanisms by which fungal pathogens cause disease.

21 Jul 2004

Study finds that 94% of air travelers would want health authorities to contact them if they have been exposed to a serious contagious disease on an airplane

A new study by the Harvard School of Public Health Project on the Public and Biological Security finds that the vast majority (94%) of air travelers would want public health authorities to contact them if they might have been exposed to a serious contagious disease on an airplane.

21 Jul 2004

Medicinal qualities of plants shown to ease symptoms of genetic disease

Phytomedicines are medicines derived from plants and often responsible for the healing effects of traditional remedies used.

21 Jul 2004

Chemotherapy aimed at both cancer cells and their genetically normal cellular 'microenvironment' might improve the success of breast cancer treatment

In the first comprehensive survey of gene activity in each cell type composing normal and malignant breast tissue, scientists at Dana-Farber Cancer Institute have identified genes in non-cancerous supporting cells that can spur the growth of breast cancer cells.

20 Jul 2004

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

CancerVax Corporation has announced that its wholly owned subsidiaries, Tarcanta, Inc., and Tarcanta, Ltd. (Ireland), have obtained the exclusive rights to complete the clinical development of three specific active immunotherapeutic (SAI) product candidates that target the epidermal growth factor receptor (EGFR) signaling pathway for the treatment of cancer.

19 Jul 2004

New compound that is designed to overcome Gleevec resistance

One of the truly spectacular success stories in modern oncology is the development and implementation of Gleevec, a drug that virtually halts the progress of chronic myeloid leukemia. Yet for some patients who harbor particularly stubborn genetic mutations, Gleevec fails miserably.

17 Jul 2004

T Cell News and Research

Latest T Cell News and Research

New plan of action aims to reduce prescription drug costs by more than 50 percent

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Innovative treatment for cancer patients who have previously undergone chemotherapy, surgery or radiotherapy

Finding helps explain how nerves connect to their targets and stop growing once there

Gene responsible for infertility

Gene associated with susceptibility to developing type 1 diabetes

New precautionary measures against the possible risk of transmission of variant Creutzfeldt Jakob Disease

Epilepsy, new therapeutic possibilities

New cream treatment for common form of skin cancer

HFEA allows families to have a child who could be a tissue match for a seriously ill brother or sister

Researchers discover how world’s most serous tropical diseases - Leishmaniasis is spread

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Researchers discover a mechanism that blocks replication of a retrovirus

Australian collaboration to produce cancer immunotherapy vaccines

European funding to study how yeasts such as Candida cause infections among hospital patients

Study finds that 94% of air travelers would want health authorities to contact them if they have been exposed to a serious contagious disease on an airplane

Medicinal qualities of plants shown to ease symptoms of genetic disease

Chemotherapy aimed at both cancer cells and their genetically normal cellular 'microenvironment' might improve the success of breast cancer treatment

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

New compound that is designed to overcome Gleevec resistance

Immunology eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in